{"id":121740,"date":"2026-04-26T16:19:18","date_gmt":"2026-04-26T15:19:18","guid":{"rendered":"https:\/\/dknews.dz\/?p=121740"},"modified":"2026-04-26T16:19:19","modified_gmt":"2026-04-26T15:19:19","slug":"lanticancereux-ifosfamide-retire-du-marche-en-raison-dun-risque-neurologique","status":"publish","type":"post","link":"https:\/\/dknews.dz\/index.php\/2026\/04\/26\/lanticancereux-ifosfamide-retire-du-marche-en-raison-dun-risque-neurologique\/","title":{"rendered":"L&rsquo;anticanc\u00e9reux Ifosfamide retir\u00e9 du march\u00e9 en raison d&rsquo;un risque neurologique"},"content":{"rendered":"\n<p>L&rsquo;Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament (ANSM) vient d&rsquo;annoncer le retrait d&rsquo;un m\u00e9dicament anticanc\u00e9reux au motif qu&rsquo;il risquerait de provoquer une maladie du cerveau.<br>\u00ab\u00a0Nous suspendons l&rsquo;autorisation de mise sur le march\u00e9 de l&rsquo;ifosfamide en solution (Ifosfamide EG) en raison d&rsquo;un risque neurologique\u00a0\u00bb expliquait sur Twitter l&rsquo;ANSM mercredi 26 ao\u00fbt, en faisant le lien vers un communiqu\u00e9 explicatif et une proposition de m\u00e9dicament de substitution.<br>En mars 2020 a d\u00e9but\u00e9 une \u00ab\u00a0r\u00e9\u00e9valuation europ\u00e9enne\u00a0\u00bb de ce traitement pour comprendre le rapport entre le risque et le b\u00e9n\u00e9fice qu&rsquo;il pr\u00e9sente. Ce risque, c&rsquo;est l&rsquo;enc\u00e9phalopathie, une maladie du cerveau. Il a \u00e9t\u00e9 r\u00e9v\u00e9l\u00e9 par une \u00e9tude de pharmacovigilance et s&rsquo;adresse uniquement \u00e0 l&rsquo;ifosfamide en solution (Ifosfamide EG) et non \u00e0 l&rsquo;ifosfamide en poudre (Holoxan) recommand\u00e9 en substitution, dont les stocks sont suffisants pour compenser.<br>Ce m\u00e9dicament anticanc\u00e9reux est prescrit chez l&rsquo;adulte comme chez l&rsquo;enfant pour le traitement de sarcomes des tissus mous et de lymphomes. Or, depuis 2015, les cas d&rsquo;enc\u00e9phalopathies d\u00e9velopp\u00e9s par des patients sous Ifosfamide EG n&rsquo;ont cess\u00e9 d&rsquo;\u00eatre recens\u00e9s. L&rsquo;agence du m\u00e9dicament suppose qu&rsquo;ils seraient dus \u00e0 une d\u00e9gradation spontan\u00e9e du produit qui engendrerait des impuret\u00e9s. En r\u00e9action \u00e0 ce risque connu, la dur\u00e9e de conservation conseill\u00e9e du m\u00e9dicament avait consid\u00e9rablement baiss\u00e9e, passant de 18 mois \u00e0 seulement 7 mois. Mais cela n&rsquo;a pas suffit \u00e0 supprimer les risques, souligne l&rsquo;ASNM.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>L&rsquo;Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament (ANSM) vient d&rsquo;annoncer le retrait d&rsquo;un m\u00e9dicament anticanc\u00e9reux au motif qu&rsquo;il risquerait de provoquer une maladie du cerveau.\u00ab\u00a0Nous suspendons l&rsquo;autorisation de mise sur le march\u00e9 de l&rsquo;ifosfamide en solution (Ifosfamide EG) en raison d&rsquo;un risque neurologique\u00a0\u00bb expliquait sur Twitter l&rsquo;ANSM mercredi 26 ao\u00fbt, en faisant le lien vers un [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":121741,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","footnotes":""},"categories":[110],"tags":[],"ppma_author":[163],"class_list":{"0":"post-121740","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-sante"},"authors":[{"term_id":163,"user_id":1,"is_guest":0,"slug":"dknews","display_name":"dknews","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/f56c36580f44a9d8e8535169273499b7dddc82045bcc254bf7d154ff6b485f62?s=96&d=mm&r=g","first_name":"","last_name":"","user_url":"https:\/\/dknews.dz","job_title":"","description":""}],"_links":{"self":[{"href":"https:\/\/dknews.dz\/index.php\/wp-json\/wp\/v2\/posts\/121740","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dknews.dz\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dknews.dz\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dknews.dz\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dknews.dz\/index.php\/wp-json\/wp\/v2\/comments?post=121740"}],"version-history":[{"count":0,"href":"https:\/\/dknews.dz\/index.php\/wp-json\/wp\/v2\/posts\/121740\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dknews.dz\/index.php\/wp-json\/wp\/v2\/media\/121741"}],"wp:attachment":[{"href":"https:\/\/dknews.dz\/index.php\/wp-json\/wp\/v2\/media?parent=121740"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dknews.dz\/index.php\/wp-json\/wp\/v2\/categories?post=121740"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dknews.dz\/index.php\/wp-json\/wp\/v2\/tags?post=121740"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/dknews.dz\/index.php\/wp-json\/wp\/v2\/ppma_author?post=121740"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}